Cargando…
Microarray profiling of hypothalamic gene expression changes in Huntington’s disease mouse models
Structural changes and neuropathology in the hypothalamus have been suggested to contribute to the non-motor manifestations of Huntington’s disease (HD), a neurodegenerative disorder caused by an expanded cytosine-adenine-guanine (CAG) repeat in the huntingtin (HTT) gene. In this study, we investiga...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671106/ https://www.ncbi.nlm.nih.gov/pubmed/36408416 http://dx.doi.org/10.3389/fnins.2022.1027269 |
_version_ | 1784832470757146624 |
---|---|
author | Dickson, Elna Dwijesha, Amoolya Sai Andersson, Natalie Lundh, Sofia Björkqvist, Maria Petersén, Åsa Soylu-Kucharz, Rana |
author_facet | Dickson, Elna Dwijesha, Amoolya Sai Andersson, Natalie Lundh, Sofia Björkqvist, Maria Petersén, Åsa Soylu-Kucharz, Rana |
author_sort | Dickson, Elna |
collection | PubMed |
description | Structural changes and neuropathology in the hypothalamus have been suggested to contribute to the non-motor manifestations of Huntington’s disease (HD), a neurodegenerative disorder caused by an expanded cytosine-adenine-guanine (CAG) repeat in the huntingtin (HTT) gene. In this study, we investigated whether hypothalamic HTT expression causes transcriptional changes. Hypothalamic RNA was isolated from two different HD mouse models and their littermate controls; BACHD mice with ubiquitous expression of full-length mutant HTT (mHTT) and wild-type mice with targeted hypothalamic overexpression of either wild-type HTT (wtHTT) or mHTT fragments. The mHTT and wtHTT groups showed the highest number of differentially expressed genes compared to the BACHD mouse model. Gene Set Enrichment Analysis (GSEA) with leading-edge analysis showed that suppressed sterol- and cholesterol metabolism were shared between hypothalamic wtHTT and mHTT overexpression. Most distinctive for mHTT overexpression was the suppression of neuroendocrine networks, in which qRT-PCR validation confirmed significant downregulation of neuropeptides with roles in feeding behavior; hypocretin neuropeptide precursor (Hcrt), tachykinin receptor 3 (Tacr3), cocaine and amphetamine-regulated transcript (Cart) and catecholamine-related biological processes; dopa decarboxylase (Ddc), histidine decarboxylase (Hdc), tyrosine hydroxylase (Th), and vasoactive intestinal peptide (Vip). In BACHD mice, few hypothalamic genes were differentially expressed compared to age-matched WT controls. However, GSEA indicated an enrichment of inflammatory- and gonadotropin-related processes at 10 months. In conclusion, we show that both wtHTT and mHTT overexpression change hypothalamic transcriptome profile, specifically mHTT, altering neuroendocrine circuits. In contrast, the ubiquitous expression of full-length mHTT in the BACHD hypothalamus moderately affects the transcriptomic profile. |
format | Online Article Text |
id | pubmed-9671106 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96711062022-11-18 Microarray profiling of hypothalamic gene expression changes in Huntington’s disease mouse models Dickson, Elna Dwijesha, Amoolya Sai Andersson, Natalie Lundh, Sofia Björkqvist, Maria Petersén, Åsa Soylu-Kucharz, Rana Front Neurosci Neuroscience Structural changes and neuropathology in the hypothalamus have been suggested to contribute to the non-motor manifestations of Huntington’s disease (HD), a neurodegenerative disorder caused by an expanded cytosine-adenine-guanine (CAG) repeat in the huntingtin (HTT) gene. In this study, we investigated whether hypothalamic HTT expression causes transcriptional changes. Hypothalamic RNA was isolated from two different HD mouse models and their littermate controls; BACHD mice with ubiquitous expression of full-length mutant HTT (mHTT) and wild-type mice with targeted hypothalamic overexpression of either wild-type HTT (wtHTT) or mHTT fragments. The mHTT and wtHTT groups showed the highest number of differentially expressed genes compared to the BACHD mouse model. Gene Set Enrichment Analysis (GSEA) with leading-edge analysis showed that suppressed sterol- and cholesterol metabolism were shared between hypothalamic wtHTT and mHTT overexpression. Most distinctive for mHTT overexpression was the suppression of neuroendocrine networks, in which qRT-PCR validation confirmed significant downregulation of neuropeptides with roles in feeding behavior; hypocretin neuropeptide precursor (Hcrt), tachykinin receptor 3 (Tacr3), cocaine and amphetamine-regulated transcript (Cart) and catecholamine-related biological processes; dopa decarboxylase (Ddc), histidine decarboxylase (Hdc), tyrosine hydroxylase (Th), and vasoactive intestinal peptide (Vip). In BACHD mice, few hypothalamic genes were differentially expressed compared to age-matched WT controls. However, GSEA indicated an enrichment of inflammatory- and gonadotropin-related processes at 10 months. In conclusion, we show that both wtHTT and mHTT overexpression change hypothalamic transcriptome profile, specifically mHTT, altering neuroendocrine circuits. In contrast, the ubiquitous expression of full-length mHTT in the BACHD hypothalamus moderately affects the transcriptomic profile. Frontiers Media S.A. 2022-11-03 /pmc/articles/PMC9671106/ /pubmed/36408416 http://dx.doi.org/10.3389/fnins.2022.1027269 Text en Copyright © 2022 Dickson, Dwijesha, Andersson, Lundh, Björkqvist, Petersén and Soylu-Kucharz. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neuroscience Dickson, Elna Dwijesha, Amoolya Sai Andersson, Natalie Lundh, Sofia Björkqvist, Maria Petersén, Åsa Soylu-Kucharz, Rana Microarray profiling of hypothalamic gene expression changes in Huntington’s disease mouse models |
title | Microarray profiling of hypothalamic gene expression changes in Huntington’s disease mouse models |
title_full | Microarray profiling of hypothalamic gene expression changes in Huntington’s disease mouse models |
title_fullStr | Microarray profiling of hypothalamic gene expression changes in Huntington’s disease mouse models |
title_full_unstemmed | Microarray profiling of hypothalamic gene expression changes in Huntington’s disease mouse models |
title_short | Microarray profiling of hypothalamic gene expression changes in Huntington’s disease mouse models |
title_sort | microarray profiling of hypothalamic gene expression changes in huntington’s disease mouse models |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671106/ https://www.ncbi.nlm.nih.gov/pubmed/36408416 http://dx.doi.org/10.3389/fnins.2022.1027269 |
work_keys_str_mv | AT dicksonelna microarrayprofilingofhypothalamicgeneexpressionchangesinhuntingtonsdiseasemousemodels AT dwijeshaamoolyasai microarrayprofilingofhypothalamicgeneexpressionchangesinhuntingtonsdiseasemousemodels AT anderssonnatalie microarrayprofilingofhypothalamicgeneexpressionchangesinhuntingtonsdiseasemousemodels AT lundhsofia microarrayprofilingofhypothalamicgeneexpressionchangesinhuntingtonsdiseasemousemodels AT bjorkqvistmaria microarrayprofilingofhypothalamicgeneexpressionchangesinhuntingtonsdiseasemousemodels AT petersenasa microarrayprofilingofhypothalamicgeneexpressionchangesinhuntingtonsdiseasemousemodels AT soylukucharzrana microarrayprofilingofhypothalamicgeneexpressionchangesinhuntingtonsdiseasemousemodels |